Publication Name	World Journal of Stem Cells
Manuscript ID	11784
Country	United States

Received	2014-06-04 08:03
Peer-Review Started	2014-06-04 22:02
To Make the First Decision	2014-06-27 12:00
Return for Revision	2014-07-07 10:03
Revised	2014-07-22 03:37
Second Decision	2014-09-01 15:16
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-09-01 15:21
Articles in Press	2014-09-01 15:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-15 12:56
Publish the Manuscript Online	2014-09-25 12:31

ISSN	1948-0210 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Minireviews
Article Title	Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
Manuscript Source	Invited Manuscript
All Author List	Christen L Walters Haygood, Rebecca C Arend, J Michael Straughn and Donald J Buchsbaum
Funding Agency and Grant Number
Corresponding Author	Christen L Walters Haygood, MD, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 1700 6th Ave South, WIC 10250, Birmingham, AL 35233, United States. cwalters@uabmc.edu
Key Words	Epithelial ovarian cancer; Cancer stem cells; Chemoresistance; Targeted therapy; Chemotherapy; Recurrent ovarian cancer
Core Tip	Ovarian cancer stem cells (CSCs) are difficult to isolate, identify, and target. However, they are often thought to be the source of development of chemoresistance. Finding a therapeutic target in ovarian CSCs and identifying the mechanisms associated with the development of chemoresistance may lead to a long-lasting cure for patients with epithelial ovarian cancer.
Publish Date	2014-09-25 12:31
Citation	Walters Haygood CL, Arend RC, Straughn JM, Buchsbaum DJ. Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival? World J Stem Cells 2014; 6(4): 441-447
URL	http://www.wjgnet.com/1948-0210/full/v6/i4/441.htm
DOI	http://dx.doi.org/10.4252/wjsc.v6.i4.441

Full Article (PDF)	WJSC-6-441.pdf
Full Article (Word)	WJSC-6-441.doc
Manuscript File	11784-Review.docx
Answering Reviewers	11784-Answering reviewers.pdf
Copyright License Agreement	11784-Copyright assignment.pdf
Peer-review Report	11784-Peer review(s).pdf
Scientific Misconduct Check	11784-CrossCheck.jpg
Scientific Editor Work List	11784-Scientific editor work list.pdf